ATT29056

Some women may wish to add subtle volume to their lips; others may want
to soften the appearance of the vertical lines above them. Lines such as
these are often caused by factors such as sun exposure or repeated
muscle movement.

Fortunately, there’s JUVÉDERM VOLBELLA® XC—the first and only
FDA-approved filler proven to increase lip fullness and soften the
appearance of vertical lip lines for up to 1 year.*
*With optimal treatment.

ATT83978

  • You would like to add subtle volume to your lips
  • You would like to soften the appearance of your vertical lip lines
  • You want natural-looking, long-lasting results
  • ATT44624
    ATT27147
    BEFORE AFTER

    ATT65479
    BEFORE AFTER

    Actual patient. Results may vary.
    Unretouched photos taken before treatment and 1 month after treatment.
    A total of 1.2 mL of JUVÉDERM VOLBELLA® XC was injected into the lips.

    ATT60181

    JUVÉDERM VOLBELLA® XC Important Information

    APPROVED USES
    JUVÉDERM VOLBELLA® XC injectable gel is for injection into the lips for lip augmentation and for correction of perioral lines in adults over the age of 21.

    IMPORTANT SAFETY INFORMATION

    Are there any reasons why I should not receive JUVÉDERM VOLBELLA® XC
    injectable gel?

    Do not use this product if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to lidocaine or Gram-positive bacterial proteins used in these products.

    What precautions should my doctor advise me about?

    • Tell your doctor if you are pregnant or breastfeeding. The safety of JUVÉDERM VOLBELLA® XC for use during pregnancy or while breastfeeding has not been studied
    • The safety of JUVÉDERM VOLBELLA® XC in patients under 22 years has not been studied
    • The safety and effectiveness of JUVÉDERM VOLBELLA® XC in areas other than the lips and perioral area have not been established in controlled clinical studies
    • Tell your doctor if you have a history of excessive scarring (eg, hypertrophic scarring and keloid formation) or pigmentation disorders, as use of JUVÉDERM VOLBELLA® XC may result in additional scars or changes in pigmentation
    • Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment
    • Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune response, as use of JUVÉDERM VOLBELLA® XC may result in an increased risk of infection
    • Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site
    • Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment

    What are possible side effects?
    The most common side effects included swelling, tenderness, bruising, firmness, lumps/bumps, redness, pain, discoloration, itching, and dryness. Most side effects were mild or moderate and lasted 30 days or less.

    One of the risks with using this product is unintentional injection into a blood vessel, and while rare, the complications can be serious and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring.

    As with all skin injection procedures, there is a risk of infection.

    To report a side effect with JUVÉDERM VOLBELLA® XC, please call Allergan at
    1-800-433-8871. Please also visit Juvederm.com for more information.

    Available by prescription only.
    ATT67901
    © 2016 Allergan. All rights reserved. All trademarks are the property of their respective owners. Juvederm.com JUV103049 10/16 163495

    If you no longer wish to receive emails from this sender about JUVÉDERM VOLBELLA® XC products and services, please reply to this email and include “unsubscribe” in the subject line.

    Allergan Privacy Statement | Terms of Use | Allergan.com